The court will decide whether Myriad Genetics, a biotechnology company, has the right to patent human genes — in this case, two gene mutations called BRCA1 and BRCA2 that increase breast cancer ...

“This patent represents another key step at a differentiated approach to help all who suffer from addiction,” said Jeffrey Kraws, CEO of Innovation1 Biotech. The Company’s clinical portfolio ...

LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”) today announced the signing of an exclusive patent license agreement with the National Institute of ...